Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease

Gene and protein expression of programmed death‐ligand 1 (PD‐L1) are prognostic in early breast cancer (BC), but their prognostic information is inconsistent at least in some biological subgroups. The validated prognostic gene signatures (GS) in BC are mainly based on proliferation and estrogen rece...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Oncol
Hlavní autoři: Zerdes, Ioannis, Sifakis, Emmanouil G., Matikas, Alexios, Chrétien, Sebastian, Tobin, Nicholas P., Hartman, Johan, Rassidakis, George Z., Bergh, Jonas, Foukakis, Theodoros
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7191187/
https://ncbi.nlm.nih.gov/pubmed/32115850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12654
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky